TWi Biotechnology completes phase II trial patient enrollment …

TWi Biotechnology has completed patient enrollment in a phase II trial of AC-201 for Gout Flare Prophylaxis (GFP) during urate-lowering therapy (ULT).

Continued here: 
TWi Biotechnology completes phase II trial patient enrollment …

No comments yet.

TOP